Efficacy of lifestyle change psychological intervention in coronary risk reduction;Eficácia de uma intervenção psicológica no estilo de vida para redução do risco coronariano

Arquivos Brasileiros de Cardiologia

Volumn 89, Issue 4, 2007, Pages 225-230

  Pugliese, Rita ^a,b   Zanella, Maria Tereza ^a   Blay, Sérgio Luís ^a   Plavinik, Frida ^a   Andrade, Marco Antonio ^a   Galvão, Roberto ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Behavioral medicine; Dyslipidemias; Hypertension; Primary prevention; Weight loss

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY RISK; DYSLIPIDEMIA; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PSYCHOLOGICAL ASPECT; RATING SCALE; RISK REDUCTION; STRESS;

ADULT; BEHAVIOR THERAPY; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; COUNSELING; DYSLIPIDEMIAS; EPIDEMIOLOGIC METHODS; FEEDING BEHAVIOR; FEMALE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; MOTOR ACTIVITY; OUTCOME ASSESSMENT (HEALTH CARE); OVERWEIGHT; RISK REDUCTION BEHAVIOR; STRESS; TRIGLYCERIDES;

EID: 37349010674     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Uemura K, Piza Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q. 1988; 41: 155-78.
2. Thom TJ. International mortality from heart disease: rates and trends. Int J Epidemiol. 1989; 18 (Suppl 1): 520-9.
3. Agewall S, Wikstrand J , Samuelsson O, Persson B, Andersson OK, Fagerberg B. The efficacy of multiple risk factor intervention in treated hypertensive men during long-term follow up. J Intern Med. 1994; 236: 651-9.
4. Fagerberg B, Wikstrand J, Berglund G, Samuelsson O, Agewall S. Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced: a randomized intervention study. Am J Hypertens. 1998; 11: 14-22.
5. Benfari RC. The Multiple Risk Factor Intervention Trial: MRFIT. Prev Med. 1981; 10: 426-42.
6. MRFIT- Mortality rates after 10,5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypothese of the trial. The Multiple Risk Factor Intervention Trial Research Group. JAMA. 1990; 263 (13): 1795-801.
7. Kjelsberg MO, Cutler JA, Dolecek TA. Brief description of the multiple risk factor intervention trial. Am J Clin Nutr. 1997; 65 (Suppl 1): 191S-195S.
8. Iacoponi E, Mari JJ. Reliability and factor structure of the Portuguese version of Self-Reporting Questionnaire. Int J Soc Psychiatry. 1989; 35 (3): 213-22.
9. Mari JJ, Williams P. A validity study of a psychiatric screening questionnaire (SRQ-20) in primary care in the city of Sao Paulo. Br J Psychiatry. 1986; 148: 23-6.
10. Wilson PWF, D' Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97: 1837-47.
11. Lipp MN, Guevara AH. Validação empírica do inventário de sintomas de estresse (ISS). Estudos de Psicologia. 1994; 11(3): 43-9.
12. Hobbs M. An introduction to the psychotherapies. In: Bloch S (ed). Shortterm dynamic psychotherapies. 3rd ed. Oxford Medical Publication; 1996. p. 52-83.
13. Sifneos P. Psicoterapia dinâmica breve - avaliação e técnica. São Paulo: Artes Médicas; 1989.
14. Hutton B, Fergusson D. Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials. Am J Clin Nutr. 2004; 80 (6): 1461-8.
15. Planas E, Fiol C, Sabate I. HDL cholesterol as a risk factor for arteriosclerosis. Med Clin. 1980; 75 (8): 331-3.
16. Orso GG. Cholesterol bound to high-density lipoproteins: critical review of methods of analysis and personal data. Ann Osp Maria Vittoria Torino. 1982; 24 (7-12): 286-306.
17. Pezzilli R, Ceciliato R, Corinaldesi R, Barakat B. Acute pancreatitis due to simvastatin therapy: increased severity after rechallenge. Dig Liver Dis. 2004; 36 (9): 639-40.
18. Ebrahim S, Smith GD. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev. 2000; 2: CD 001561.
19. Thompson PD, Buchner D, Piña IL, Balady GJ, Williams MA, Marcus BH, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Circulation. 2003; 107 (24): 3109-16.
20. Ginsberg HN. Nonpharmacologic management of low levels of high-density lipoprotein cholesterol. Am J Cardiol. 2000; 86 (12A): 41L-45L